Banner NPRA

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

New Publication: Reaksi Drug Safety News - Issue 3/2017

Kadar pengguna: 1 / 5

bintang aktifBintang tidak aktifBintang tidak aktifBintang tidak aktifBintang tidak aktif
 

REAKSI Drug Safety News,

Issue 3/2017

 

  • Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse
  • Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B Reactivation, Herpes Zoster and Pulmonary Hypertension

 



 
 
  DOWNLOAD PDF


 

 

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Isnin 30 Disember 2024, 16:47:14.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Menu Utama